Popular on EntSun
- Sea Tales Strengthens U.S. Leadership Team as Retail Expansion Accelerates - 409
- Stitt Entertainment Names Tristan Xavier Lead Stylist - 340
- ChargeOn Announces Conversational Payment Management Solution - 337
- Mecca to Mars: Earth's Escape? - 245
- Robert DeMaio, Phinge CEO to Speak at 30th IIPLA 2026 on Securing IP, User Data & Digital Sovereignty via Verified App-less Tech. Attend the Live Q&A! - 226
- Rehearsals Begin on 'The Call List' by Brian James Polak - 211
- Free JavaScript Charting Library ProEssentialsJS Permits Commercial Use. Highcharts, SciChart and LightningChart Free Tiers Do Not - 209
- Volant Announces Major Partnership with the STEM Racing Canada Program to CHAMPION YOUTH ENGINEERING - 198
- Big Panic Records Announces "African Sunshine" by Believe, Shirley Jones & Omasta - 195
- Yalil Guerra's "Clave" to Receive World Premiere in New Symphonic Version at The Soraya - 178
Similar on EntSun
- Retell AI White Label Platform for Agencies Launched by VoiceAIWrapper, With Branded Client Portals and No Per-Minute Markup
- Notaron Expands Online Notarization Access Following Wisconsin Approval
- Wings Air Helicopters Selected to Support VIP Transportation for Resorts World in New York
- Scoop Social Co. Brings Its Signature Mobile Dessert Experience to Houston This October
- The Social Capital Revolution Comes to Phoenix!
- Super Rooter Expands to 190 Plumbing, Sewer, and Drain Service Locations Across the United States
- European Patent for ALS Program Expands the Story: HOPE Deploys Robotic TMS & FDA Commercialization Path Advances: NRx Pharmaceuticals: NAS DAQ: NRXP
- Congressman Chuck Edwards (NC-11) Presents ReadyCommunities Partnership 2026 National Service Award to Local Businessman / US Air Force Veteran
- FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
- Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
JDRF Applauds Usher and NFL Star Noah Gray for Shining a Spotlight on Type 1 Diabetes at Super Bowl LVIII
EntSun News/11015177
NEW YORK, Feb. 12, 2024 ~ JDRF, the leading global organization for type 1 diabetes (T1D) research and advocacy, has recognized two individuals for their efforts in raising awareness for the disease during Super Bowl LVIII. Grammy award-winning artist Usher and NFL Super Bowl Champion Noah Gray of the Kansas City Chiefs have both been acknowledged for shining a spotlight on T1D.
Usher, whose teenage son was diagnosed with T1D at the age of six, used his platform as he prepared for his highly anticipated Super Bowl Halftime Show and the release of his upcoming album to bring attention to T1D and the importance of early detection. In various media interviews leading up to the event, Usher shared his personal journey as a parent of a child with T1D and stressed the need for greater knowledge and understanding about the disease.
According to JDRF CEO Aaron Kowalski, Usher's advocacy has played a crucial role in raising awareness about T1D and promoting early detection through screening. By educating people about the symptoms of T1D and encouraging them to get screened, there is a reduced risk of life-threatening complications and hospitalizations during diagnosis. Additionally, early detection allows families time to plan, prepare, and possibly benefit from therapies that can delay the onset of T1D.
More on EntSun News
Noah Gray, a standout tight end for the Kansas City Chiefs, was diagnosed with T1D during his freshman year at Duke University. Despite this challenge, Gray remained determined to pursue his dreams and learned how to manage his diabetes while excelling academically and athletically. His hard work paid off when he was selected by the Chiefs in the 2021 NFL draft. Gray played a significant role in helping his team win Super Bowl LVIII against the San Francisco 49ers yesterday, adding another championship title to his resume. He serves as an inspiration for individuals with T1D that with hard work and access to the right tools, they can compete in sports at every level.
T1D is an autoimmune disease that affects over 1.4 million Americans. It causes the pancreas to produce little or no insulin, and those with T1D must carefully monitor their blood glucose levels and administer insulin to survive. This condition can affect people of any age, and currently, there is no cure.
More on EntSun News
JDRF emphasizes the importance of T1D screening, which involves a blood test to check for specific autoantibodies that indicate the body's immune system is attacking the insulin-producing cells in the pancreas. Screening allows families to plan and prepare for a potential diagnosis and prevent severe complications like diabetic ketoacidosis (DKA) and hospitalization. It also opens up opportunities for individuals to receive therapies that can delay the onset of T1D or participate in studies for other innovative treatment options.
To learn more about T1D screening, JDRF's education and awareness program T1Detect provides information on where to get screened and what steps to take after receiving results. Visit JDRF.org/T1Detect for more information.
Usher, whose teenage son was diagnosed with T1D at the age of six, used his platform as he prepared for his highly anticipated Super Bowl Halftime Show and the release of his upcoming album to bring attention to T1D and the importance of early detection. In various media interviews leading up to the event, Usher shared his personal journey as a parent of a child with T1D and stressed the need for greater knowledge and understanding about the disease.
According to JDRF CEO Aaron Kowalski, Usher's advocacy has played a crucial role in raising awareness about T1D and promoting early detection through screening. By educating people about the symptoms of T1D and encouraging them to get screened, there is a reduced risk of life-threatening complications and hospitalizations during diagnosis. Additionally, early detection allows families time to plan, prepare, and possibly benefit from therapies that can delay the onset of T1D.
More on EntSun News
- Michael H. Kaplan Recognized for 17 Years on PHPA Workers' Compensation Panel and Advocacy for Professional Athletes
- International Society of Medical AI Convenes Global Faculty in Florence for ISMAI 2026
- Boston Industrial Solutions Introduces Personalized Printing Training
- Century Fasteners de Mexico Exhibiting at the 2026 Automotive & Aerospace Nearshoring Summit
- Lovecraft In Florida Blu-Ray Release
Noah Gray, a standout tight end for the Kansas City Chiefs, was diagnosed with T1D during his freshman year at Duke University. Despite this challenge, Gray remained determined to pursue his dreams and learned how to manage his diabetes while excelling academically and athletically. His hard work paid off when he was selected by the Chiefs in the 2021 NFL draft. Gray played a significant role in helping his team win Super Bowl LVIII against the San Francisco 49ers yesterday, adding another championship title to his resume. He serves as an inspiration for individuals with T1D that with hard work and access to the right tools, they can compete in sports at every level.
T1D is an autoimmune disease that affects over 1.4 million Americans. It causes the pancreas to produce little or no insulin, and those with T1D must carefully monitor their blood glucose levels and administer insulin to survive. This condition can affect people of any age, and currently, there is no cure.
More on EntSun News
- Retell AI White Label Platform for Agencies Launched by VoiceAIWrapper, With Branded Client Portals and No Per-Minute Markup
- Events by Dubsdread Celebrates Cultural Traditions with New Guide on Faith-Based Wedding Traditions Across Cultures
- FOCUS Names Mark Phillips Senior Vice President of Business Development
- Get The Led Out Bring an Outstanding Tribute to Led Zeppelin to the Weinberg Center
- Cemetery Cinema is now available for Syndication!!!!
JDRF emphasizes the importance of T1D screening, which involves a blood test to check for specific autoantibodies that indicate the body's immune system is attacking the insulin-producing cells in the pancreas. Screening allows families to plan and prepare for a potential diagnosis and prevent severe complications like diabetic ketoacidosis (DKA) and hospitalization. It also opens up opportunities for individuals to receive therapies that can delay the onset of T1D or participate in studies for other innovative treatment options.
To learn more about T1D screening, JDRF's education and awareness program T1Detect provides information on where to get screened and what steps to take after receiving results. Visit JDRF.org/T1Detect for more information.
Filed Under: Business
0 Comments
Latest on EntSun News
- European Patent for ALS Program Expands the Story: HOPE Deploys Robotic TMS & FDA Commercialization Path Advances: NRx Pharmaceuticals: NAS DAQ: NRXP
- VICTURY Sports Announces Formation of Youth Sports League Built on the Official, Patented, and Award-Winning Keepy Uppy® Ball
- GOOBZ'D™ Turns "Did You Mean: Good?" Search Confusion Into a New Campaign
- The Podcast of Power Returns With Exclusive Bear McCreary Interview
- Berkshire Actor Charlotte Drablow Expands Screen Career
- GOOBZ'D™ Begins Official Character Rollout With CHOMPZ, Character #001
- Making Time for Mythic Adventure
- High Rise 6: Power to Escape Expands the Film Franchise With New Cartels, New Locations
- Congressman Chuck Edwards (NC-11) Presents ReadyCommunities Partnership 2026 National Service Award to Local Businessman / US Air Force Veteran
- Cress Creeks Farm Opens Fall Corn Maze and Baby Lamb Hayride Experience in Ellijay, Georgia
- Allstream Energy Partners Nominated in Multiple Categories for Fast Company's Best Workplaces for Innovators
- Hustle, Salsa & Bachata dance class at BigShots Roswell inside You42 Studio
- Pebble Photo Booths Brings Modern Photo Experiences to Vancouver, Washington
- Chicago Creator Aaron Devere Unveils GOOBZ'D™, an Original Animated and Collectible Universe
- Kerri Lawless Introduces New Home-Selling Option for Local Homeowners
- Emmy Nominee Sepideh Moafi And Peabody Award Winner Aasif Mandvi To Receive Cultural Impact Awards
- Originality Isn't Scarcity. Perspective Is
- FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
- Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
- Dwayne Buckle's Visionary 3D Feature Film Explores Power, Corruption, Truth & the Future of Humanity